XML 67 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segment Information (Tables)
9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Summary of Revenue and Gross Profit The results of each segment are regularly reviewed by the Company’s Chief Executive Officer, who is the Company’s chief operating decision maker, to assess the performance of the segment and make decisions regarding the allocation of resources. The Company’s chief operating decision maker uses revenue and gross profit as the measure of segment profit or loss. The accounting policies of each segment are the same as those set out under the summary of significant accounting policies in Note 1. There are no intersegment sales or transfers.

The comparative three and nine months ended September 30, 2019 have been recast to reflect to the current segment structure.

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

Revenue

 

 

Gross profit / (loss)

 

 

Revenue

 

 

Gross profit

 

 

Revenue

 

 

Gross profit / (loss)

 

 

Revenue

 

 

Gross profit

 

Cannabis

 

$

31,426

 

 

$

(4,717

)

 

$

35,451

 

 

$

9,225

 

 

$

92,373

 

 

$

(13,863

)

 

$

78,876

 

 

$

16,213

 

Hemp

 

$

19,980

 

 

$

8,456

 

 

$

15,650

 

 

$

6,628

 

 

$

61,549

 

 

$

23,053

 

 

$

41,167

 

 

$

17,298

 

Total

 

$

51,406

 

 

$

3,739

 

 

$

51,101

 

 

$

15,853

 

 

$

153,922

 

 

$

9,190

 

 

$

120,043

 

 

$

33,511

 

No asset information is provided for the segments because the Company’s chief operating decision maker does not review this information by segment on a regular basis.

Total revenue and gross profit for the reportable segments is equal to the Company’s consolidated revenue and gross profit.

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Gross profit for the segments

 

$

3,739

 

 

$

15,853

 

 

$

9,190

 

 

$

33,511

 

General and administrative expenses

 

 

12,665

 

 

 

20,122

 

 

 

49,030

 

 

 

49,618

 

Sales and marketing expenses

 

 

10,000

 

 

 

16,974

 

 

 

40,709

 

 

 

39,161

 

Research and development expenses

 

 

921

 

 

 

2,315

 

 

 

2,831

 

 

 

4,891

 

Depreciation and amortization expenses

 

 

3,425

 

 

 

3,200

 

 

 

10,353

 

 

 

7,457

 

Stock-based compensation expenses

 

 

8,080

 

 

 

8,644

 

 

 

23,404

 

 

 

22,303

 

Impairment of assets

 

 

 

 

 

 

 

 

58,210

 

 

 

 

Acquisition-related expenses (income), net

 

 

 

 

 

(13,454

)

 

 

 

 

 

(6,566

)

Loss from equity method investments

 

 

1,420

 

 

 

1,837

 

 

 

4,495

 

 

 

1,837

 

Foreign exchange (gain) loss, net

 

 

(9,319

)

 

 

2,585

 

 

 

5,424

 

 

 

1,153

 

Change in fair value of warrant liability

 

 

(31,913

)

 

 

 

 

 

51,275

 

 

 

 

Interest expenses, net

 

 

10,437

 

 

 

8,680

 

 

 

30,147

 

 

 

26,005

 

Finance income from ABG

 

 

 

 

 

(210

)

 

 

 

 

 

(557

)

Other expense (income), net

 

 

(38

)

 

 

(1,116

)

 

 

4,944

 

 

 

(6,185

)

Loss before income taxes

 

$

(1,939

)

 

$

(33,724

)

 

$

(271,632

)

 

$

(105,606

)

Sources of revenue were as follows:

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Dried cannabis

 

$

21,079

 

 

$

29,412

 

 

$

61,339

 

 

$

62,214

 

Cannabis extracts

 

 

10,239

 

 

 

5,819

 

 

 

30,246

 

 

 

16,172

 

Hemp products

 

 

19,980

 

 

 

15,650

 

 

 

61,549

 

 

 

41,167

 

Accessories and other

 

 

108

 

 

 

220

 

 

 

788

 

 

 

490

 

Total

 

$

51,406

 

 

$

51,101

 

 

$

153,922

 

 

$

120,043

 

 

Channels of revenue were as follows:

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cannabis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adult-use

 

$

19,926

 

 

$

15,835

 

 

$

58,466

 

 

$

38,758

 

Canada - medical

 

 

3,399

 

 

 

3,898

 

 

 

11,285

 

 

 

9,222

 

International - medical

 

 

8,101

 

 

 

5,708

 

 

 

22,220

 

 

 

9,370

 

Bulk

 

 

 

 

 

10,010

 

 

 

402

 

 

 

21,526

 

Total Cannabis revenue

 

$

31,426

 

 

$

35,451

 

 

$

92,373

 

 

$

78,876

 

Hemp

 

 

19,980

 

 

 

15,650

 

 

 

61,549

 

 

 

41,167

 

Total

 

$

51,406

 

 

$

51,101

 

 

$

153,922

 

 

$

120,043

 

Summary of Revenue Attributed to a Geographic Region Based on the Location of the Customer

 

Revenue attributed to geographic region based on the location of the customer was as follows:

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Canada

 

$

29,475

 

 

$

33,585

 

 

$

86,807

 

 

$

81,138

 

United States

 

 

13,340

 

 

 

10,836

 

 

 

43,851

 

 

 

28,407

 

Other countries

 

 

8,591

 

 

 

6,680

 

 

 

23,264

 

 

 

10,498

 

Total

 

$

51,406

 

 

$

51,101

 

 

$

153,922

 

 

$

120,043

 

Summary of Long-lived Assets Consisting of Property and Equipment, Net of Accumulated Depreciation, Attributed to Geographic Regions Based on their Physical Location

Long-lived assets consisting of property and equipment, net of accumulated depreciation, attributed to geographic regions based on their physical location were as follows:

 

 

September 30, 2020

 

 

December 31, 2019

 

Canada

 

$

115,711

 

 

$

144,065

 

Portugal

 

 

67,198

 

 

 

36,908

 

United States

 

 

4,659

 

 

 

3,171

 

Other countries

 

 

62

 

 

 

73

 

Total

 

$

187,630

 

 

$

184,217